FDA unveils new COVID-19 framework, restricting shots to elderly and high-risk people
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesCBERCoronavirus/COVID-19Regulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)